為探討p21ras和nm23H1表達(dá)與胃癌淋巴結(jié)轉(zhuǎn)移的關(guān)系,采用LSAB法觀察了80例胃癌患者的p21ras和nm23H1的表達(dá),并分析其與淋巴結(jié)轉(zhuǎn)移的關(guān)系。結(jié)果:有淋巴結(jié)轉(zhuǎn)移(LNM)組p21ras表達(dá)陽(yáng)性率(62.5%)明顯高于無(wú)LNM組(42.5%),但nm23H1表達(dá)陽(yáng)性率(27.5%)則明顯低于無(wú)LNM組(47.5%);LNM數(shù)為1～3枚的p21ras表達(dá)陽(yáng)性率(33.3%)明顯低于4～7枚和 gt;8枚的LNM組(45.8%和71.4%);N1組的表達(dá)陽(yáng)性率(36.4%)明顯低于N2和N3組(52.2%和83.3%)。LNM為1～3枚的nm23H1表達(dá)陽(yáng)性率(44.4%)明顯高于4～7枚和 gt;8枚的LNM組(25.0%和0%),LNM為4～7枚組的nm23H1表達(dá)陽(yáng)性率明顯高于 gt;8枚組;N1組nm23H1表達(dá)陽(yáng)性率(45.5%)明顯高于N2和N3組(21.7%和0%)。上述結(jié)果提示,胃癌p21ras和nm23H1的表達(dá)與淋巴結(jié)轉(zhuǎn)移密切相關(guān),可作為胃癌患者預(yù)測(cè)轉(zhuǎn)移和預(yù)后的指標(biāo)。
引用本文： 秦環(huán)龍,毛明華,張惠箴. p21ras和nm23H1表達(dá)與胃癌淋巴結(jié)轉(zhuǎn)移的關(guān)系. 中國(guó)普外基礎(chǔ)與臨床雜志, 1999, 6(4): 221-223. doi: 復(fù)制
版權(quán)信息： ?四川大學(xué)華西醫(yī)院華西期刊社《中國(guó)普外基礎(chǔ)與臨床雜志》版權(quán)所有，未經(jīng)授權(quán)不得轉(zhuǎn)載、改編
| 1. | YakamaM,FujimoriT,MaedaS,etal.Comparativeclinicopathologicalandimmunohistochemicalstudyofrasandp53infatandpolypoidtypecolorectaltumors.Gut,1994;35(121)∶1258. |
| 2. | 張延齡.胃癌預(yù)后因素的研究近況.國(guó)外醫(yī)學(xué)外科學(xué)分冊(cè),1998;25(3)∶139. |
| 3. | SteegPS,BevilacquaG,KopperL,etal.Evidenceforanovelgeneassociatedwithlowtumormetastaticpotential.JNatlCancerInst,1988;80∶200. |
| 4. | LeoneA,FlatowU,KingCR,etal.Reducedtumorincidence,metastaticpotential,andcytorineresponsivenessofnm23transfectedmelanomacells.Cell,1991;65∶25. |
| 5. | 王盛乾,洪東旭,吳若華.120例胃癌中p16,nm23H1基因蛋白表達(dá)與臨床預(yù)后的關(guān)系.實(shí)用腫瘤雜志,1997;12(3)∶108. |
| 6. | KwonSJ,KimGS.Prognosticsignificanceoflymphnodemetastasisadvancedcarcinomaofthestomach.BrJSurg,1996;83(1)∶1600. |
| 7. | AllgayerH,HeissMM,SchildbergFW.Prognosisfactorsingastriccancer.BrJSurg,1997;84(176)∶1651. |
| 8. | MaeharaY,TomisakiS,OdaS,etal.Lymphnodemetastasisandrelationtotumorgrowthpotentialandlocalimmuneresponseinadvancedgastriccancer.IntJCancer,1997;74(2)∶224. |
- 1. YakamaM,FujimoriT,MaedaS,etal.Comparativeclinicopathologicalandimmunohistochemicalstudyofrasandp53infatandpolypoidtypecolorectaltumors.Gut,1994;35(121)∶1258.
- 2. 張延齡.胃癌預(yù)后因素的研究近況.國(guó)外醫(yī)學(xué)外科學(xué)分冊(cè),1998;25(3)∶139.
- 3. SteegPS,BevilacquaG,KopperL,etal.Evidenceforanovelgeneassociatedwithlowtumormetastaticpotential.JNatlCancerInst,1988;80∶200.
- 4. LeoneA,FlatowU,KingCR,etal.Reducedtumorincidence,metastaticpotential,andcytorineresponsivenessofnm23transfectedmelanomacells.Cell,1991;65∶25.
- 5. 王盛乾,洪東旭,吳若華.120例胃癌中p16,nm23H1基因蛋白表達(dá)與臨床預(yù)后的關(guān)系.實(shí)用腫瘤雜志,1997;12(3)∶108.
- 6. KwonSJ,KimGS.Prognosticsignificanceoflymphnodemetastasisadvancedcarcinomaofthestomach.BrJSurg,1996;83(1)∶1600.
- 7. AllgayerH,HeissMM,SchildbergFW.Prognosisfactorsingastriccancer.BrJSurg,1997;84(176)∶1651.
- 8. MaeharaY,TomisakiS,OdaS,etal.Lymphnodemetastasisandrelationtotumorgrowthpotentialandlocalimmuneresponseinadvancedgastriccancer.IntJCancer,1997;74(2)∶224.